openPR Logo

Press Releases from Dengue Vaccine Market (5 total)

Dengue Vaccine Market to 2027: Takeda Pharmaceutical Company Limited, Panacea Bi …

Research Solution Insights presents professional and in-depth study of "Dengue Vaccine Market: Global Industry Analysis, Size, Sales and Forecast By 2027". Dengue is a mosquito-born flavivirus disease which causes dengue fever characterized by severe headache, skin rash, debilitating muscle, joint pain leaving a feverish feeling. The dengue fever is also called as ‘breakbone fever’ due to the symptoms it causes. The symptoms for dengue start appearing in the span of 3-14

Dengue Vaccine Market to 2027: includeSanofi, Takeda Pharmaceutical Company Limi …

Research Solution Insights presents professional and in-depth study of "Dengue Vaccine Market: Global Industry Analysis, Size, Sales and Forecast By 2027". Dengue is a mosquito-born flavivirus disease which causes dengue fever characterized by severe headache, skin rash, debilitating muscle, joint pain leaving a feverish feeling. The dengue fever is also called as ‘breakbone fever’ due to the symptoms it causes. The symptoms for dengue start appearing in the span of 3-14

Dengue Vaccine Market is expected to expand at a 17.5% CAGR over the forecast pe …

Researchmoz added Most up-to-date research on "Dengue Vaccine Market: Contribution of NGOs for Better Vaccine Access Expected to Drive the Market in Lower Income Countries: Global Industry Analysis & Opportunity Assessment, 2017 - 2027" to its huge collection of research reports. Global dengue vaccine market revenue is expected to expand at a significant rate owing to a large unmet need The first dengue vaccine, Dengvaxia (CYD-TDV) developed by Sanofi Pasteur is registered

Global Dengue Vaccine Market to Grow at a CAGR of 15.05% By 2021

Albany, NY,12th January : Recent research and the current scenario as well as future market potential of "Global Dengue Vaccine Market 2017-2021" globally. The Aedes aegypti mosquito is responsible for transmitting the dengue virus (DENV). The virus that causes dengue belongs to the Flavivirus genus of the Flaviviridae family. Get PDF for more Professional and Technical insights @ https://www.researchmoz.us/enquiry.php?type=S&repid=1476387 Dengue fever resembles influenza and affects adults, children, as well as infants, but it

Analysis of Dengue Vaccine Market in Global Industry : Market Development, Overv …

Albany, NY, 5th December : Recent research and the current scenario as well as future market potential of "Dengue Vaccine Market: Contribution of NGOs for Better Vaccine Access Expected to Drive the Market in Lower Income Countries: Global Industry Analysis & Opportunity Assessment, 2017 - 2027" globally. The first dengue vaccine, Dengvaxia (CYD-TDV) developed by Sanofi Pasteur is registered in 14 countries in the Latin America and Asia Pacific region. CYD-TDV